# SPRB (Spruce Biosciences, Inc.) - SEC EDGAR Financial Statements

> Spruce Biosciences, Inc. reported $0 in revenue and a net loss of $67.15M for the fiscal year ended December 31, 2025 (down 100.0% year over year).

- Canonical: https://convexityos.com/fundamentals/SPRB
- Markdown: https://convexityos.com/fundamentals/SPRB.md
- SEC CIK: 0001683553
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:47 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001683553&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $0 | -100.0% YoY |
| Operating Income | FY 2025 | -$63.58M | Operating profit |
| Net Income | FY 2025 | -$67.15M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$23.80 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $87.69M | Total debt: $7.98M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $4.91M | $10.09M | $0 | -- | -- | -- |
| Research & Development | $19.52M | $46.42M | $49.43M | $35.20M | $30.70M | $23.85M | $10.82M |
| Total Operating Expenses | $36.51M | $61.06M | $62.08M | $47.28M | $42.07M | $29.42M | $13.11M |
| **Operating Income** | -$36.51M | -$56.15M | -$51.99M | -$47.28M | -$42.07M | -$29.42M | -$13.11M |
| **EBITDA** | -$36.49M | -$56.10M | -$51.92M | -$47.21M | -$42.00M | -$29.38M | -$13.10M |
| Interest Expense | $90K | $307K | $483K | $420K | $345K | $323K | $65K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$38.97M | -$53.04M | -$47.92M | -$46.18M | -$42.29M | -$29.54M | -$13.09M |
| Basic EPS | -$50.83 | -$96.40 | -$93.23 | -$147.37 | -$136.09 | -$370.68 | -$1,287.22 |
| **Diluted EPS** | -$50.83 | -$96.40 | -$93.23 | -$147.37 | -$136.09 | -$370.68 | -$1,287.22 |
| Basic Shares Outstanding | 766.6K | 550.1K | 512.2K | 312.9K | 310.7K | 79.7K | 10.2K |
| Diluted Shares Outstanding | 766.6K | 550.1K | 512.2K | 312.9K | 310.7K | 79.7K | 10.2K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | $0 | $0 | $0 | $0 | $697K |
| Research & Development | $18.13M | $12.16M | $7.58M | $4.10M | $5.01M | -$430K | $10.84M | $21.46M |
| Total Operating Expenses | $23.98M | $16.51M | $11.99M | $11.10M | $8.23M | $2.69M | $14.49M | $24.77M |
| **Operating Income** | -$23.98M | -$16.51M | -$11.99M | -$11.10M | -$8.23M | -$2.69M | -$14.49M | -$24.07M |
| **EBITDA** | -$23.24M | -$15.88M | -$11.73M | -$11.10M | -$8.23M | -$2.69M | -$14.49M | -$24.07M |
| Interest Expense | $1.20M | $1.10M | $674K | $6.0K | $19K | $29K | $36K | $56K |
| **Net Income** | -$24.01M | -$16.23M | -$12.27M | -$14.65M | -$8.21M | -$2.07M | -$14.04M | -$23.56M |
| Basic EPS | -$8.51 | -$6.68 | -$8.94 | -- | -$14.58 | -$3.50 | -$23.95 | -- |
| **Diluted EPS** | -$8.51 | -$6.68 | -$8.94 | -- | -$14.58 | -$3.50 | -$23.95 | -- |
| Basic Shares Outstanding | 2.8M | 2.4M | 1.4M | -- | 563.1K | 591.1K | 586.1K | -- |
| Diluted Shares Outstanding | 2.8M | 2.4M | 1.4M | -- | 563.1K | 591.1K | 586.1K | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $48.91M | $38.75M | $96.34M | $24.49M | $42.75M | $157.2M | $3.92M |
| Short-Term Investments | -- | -- | $0 | $54.59M | $46.22M | -- | -- |
| **Cash & Short-Term Investments** | $48.90M | $38.80M | $96.30M | $79.10M | $88.97M | $157.2M | $3.92M |
| Accounts Receivable, Net | -- | -- | -- | $0 | -- | -- | -- |
| Other Current Assets | $2.85M | $2.28M | $1.97M | $1.21M | $396K | $276K | $513K |
| **Total Current Assets** | $52.11M | $44.21M | $102.2M | $83.61M | $91.89M | $160.4M | $4.65M |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | $140K | $73K | -- |
| Long-Term Investments | -- | -- | -- | $0 | $32.46M | -- | -- |
| Other Non-Current Assets | $243K | $69K | $582K | $640K | $653K | $477K | $40K |
| **Total Non-Current Assets** | $909K | $1.00M | $1.76M | $2.04M | $34.59M | $2.49M | $40K |
| **Total Assets** | $53.02M | $45.21M | $103.9M | $85.65M | $126.5M | $162.9M | $4.69M |
| Accounts Payable | $943K | $1.29M | $3.33M | $1.43M | $2.82M | $3.63M | $1.88M |
| Short-Term Debt | $0 | $1.62M | $1.62M | $1.62M | $0 | $2.55M | $1.25M |
| Deferred Revenue (Current) | -- | $0 | $4.91M | $0 | -- | -- | -- |
| **Total Current Liabilities** | $10.09M | $15.25M | $24.46M | $12.45M | $8.87M | $9.76M | $4.30M |
| Long-Term Debt | $0 | $124K | $1.72M | $3.29M | $4.88M | $1.92M | $3.19M |
| Deferred Revenue (Non-Current) | -- | -- | -- | $0 | -- | -- | -- |
| Other Non-Current Liabilities | $0 | $282K | $236K | $161K | $73K | $118K | $20K |
| **Total Non-Current Liabilities** | $419K | $1.14M | $2.97M | $4.71M | $6.24M | $3.69M | $3.21M |
| **Total Liabilities** | $10.51M | $16.39M | $27.44M | $17.16M | $15.12M | $13.46M | $7.52M |
| **Total Debt (incl. Leases)** | $736K | $2.77M | $4.61M | $6.32M | $6.53M | $6.38M | $4.45M |
| Common Stock | $0 | $0 | $4.0K | $3.0K | $3.0K | $2.0K | $1.0K |
| Retained Earnings | -$289.2M | -$250.3M | -$197.2M | -$149.3M | -$103.1M | -$60.84M | -$31.30M |
| Accumulated Other Comp. Income | -- | -- | $0 | -$558K | -$184K | -- | -- |
| **Total Stockholders' Equity** | $42.52M | $28.82M | $76.51M | $68.49M | $111.4M | $149.4M | -$30.64M |
| Total Equity | $42.52M | $28.82M | $76.51M | $68.49M | $111.4M | $149.4M | -$30.64M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $87.69M | $96.30M | $54.08M | $48.91M | $10.67M | $16.39M | $25.61M | $38.75M |
| **Cash & Short-Term Investments** | $87.70M | $96.30M | $54.10M | $48.90M | $10.70M | $16.40M | $25.60M | $38.80M |
| Other Current Assets | $203K | $234K | $88K | $2.85M | $2.92M | $2.70M | $2.06M | $2.28M |
| **Total Current Assets** | $90.30M | $101.2M | $55.03M | $52.11M | $14.52M | $20.95M | $30.58M | $44.21M |
| Other Non-Current Assets | $1.20M | $1.18M | $539K | $243K | $62K | $64K | $204K | $69K |
| **Total Non-Current Assets** | $1.65M | $1.70M | $1.13M | $909K | $797K | $867K | $1.07M | $1.00M |
| **Total Assets** | $91.95M | $102.9M | $56.17M | $53.02M | $15.31M | $21.82M | $31.65M | $45.21M |
| Accounts Payable | $2.73M | $1.21M | $2.68M | $943K | $1.39M | $807K | $1.88M | $1.29M |
| Short-Term Debt | $4.00M | $2.50M | $1.00M | $0 | $539K | $943K | $1.34M | $1.62M |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Current Liabilities** | $18.71M | $10.96M | $11.78M | $10.09M | $9.43M | $8.06M | $15.67M | $15.25M |
| Long-Term Debt | $3.82M | $4.59M | $5.46M | $0 | $0 | $0 | $0 | $124K |
| Other Non-Current Liabilities | -- | -- | -- | $0 | $0 | $0 | $0 | $282K |
| **Total Non-Current Liabilities** | $6.94M | $8.16M | $9.73M | $419K | $500K | $580K | $659K | $1.14M |
| **Total Liabilities** | $25.65M | $19.12M | $21.52M | $10.51M | $9.93M | $8.64M | $16.32M | $16.39M |
| **Total Debt (incl. Leases)** | $7.98M | $7.34M | $6.80M | $736K | $1.04M | $1.52M | $2.00M | $2.77M |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $4.0K | $0 |
| Retained Earnings | -$341.7M | -$317.7M | -$301.5M | -$289.2M | -$274.6M | -$266.4M | -$264.3M | -$250.3M |
| **Total Stockholders' Equity** | $66.30M | $83.73M | $34.65M | $42.52M | $5.39M | $13.18M | $15.32M | $28.82M |
| Total Equity | $66.30M | $83.73M | $34.65M | $42.52M | $5.39M | $13.18M | $15.32M | $28.82M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$38.97M | -$53.04M | -$47.92M | -$46.18M | -$42.29M | -$29.54M | -$13.09M |
| Depreciation & Amortization | $21K | $46K | $70K | $74K | $68K | $36K | $12K |
| Stock-Based Compensation | $2.57M | $5.35M | $4.62M | $3.63M | $3.96M | $755K | $196K |
| Change in Payables | -$352K | -$2.04M | $1.91M | -$1.40M | -$805K | -- | -- |
| **Operating Cash Flow** | -$33.33M | -$55.96M | -$33.27M | -$41.68M | -$35.88M | -$27.52M | -$12.62M |
| Capital Expenditure | -- | $0 | -$7.0K | -$8.0K | -$93K | -$74K | -$4.0K |
| **Free Cash Flow** | -- | -$55.96M | -$33.28M | -$41.69M | -$35.97M | -$27.59M | -$12.62M |
| Purchases of Investments | -- | $0 | -$11.88M | -$36.80M | -$79.08M | -- | -- |
| Sales & Maturities of Investments | -- | $0 | $67.67M | $60.50M | $0 | -- | -- |
| **Investing Cash Flow** | -- | $0 | $55.78M | $23.69M | -$79.17M | -$74K | -$4.0K |
| **Financing Cash Flow** | $43.48M | -$1.62M | $49.14M | -$241K | $643K | $181.0M | $12.43M |
| **Net Change in Cash** | $10.15M | -$57.59M | $71.64M | -$18.23M | -$114.4M | $153.4M | -$188K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$24.01M | -$16.23M | -$12.27M | -$14.65M | -$8.21M | -$2.07M | -$14.04M | -$23.56M |
| Depreciation & Amortization | $738K | $631K | $252K | $5.0K | $3.0K | $7.0K | $6.0K | $9.0K |
| Stock-Based Compensation | $1.10M | $871K | $689K | $1.69M | $415K | -$77K | $544K | $961K |
| Change in Payables | $1.52M | -$1.43M | $1.70M | -$443K | $579K | -$1.07M | $584K | -$504K |
| **Operating Cash Flow** | -$13.76M | -$22.12M | -$8.73M | -$6.46M | -$5.32M | -$8.83M | -$12.73M | -$20.68M |
| Capital Expenditure | $0 | -$135K | -$10K | -- | $0 | $0 | $0 | -- |
| **Free Cash Flow** | -$13.76M | -$22.25M | -$8.74M | -- | -$5.32M | -$8.83M | -$12.73M | -- |
| Purchases of Investments | -- | -- | -- | -- | -- | -- | -- | $0 |
| Sales & Maturities of Investments | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Investing Cash Flow** | $0 | -$135K | -$10K | -- | $0 | $0 | $0 | $0 |
| **Financing Cash Flow** | $5.16M | $64.47M | $13.92M | $44.69M | -$402K | -$400K | -$411K | -$625K |
| **Net Change in Cash** | -$8.60M | $42.22M | $5.17M | $38.24M | -$5.72M | -$9.23M | -$13.14M | -$21.30M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -1143.4% | -515.3% | -- | -- | -- | -- |
| **Net Profit Margin** | -- | -1079.9% | -475.0% | -- | -- | -- | -- |
| Return on Equity (ROE) | -91.7% | -184.0% | -62.6% | -67.4% | -38.0% | -19.8% | -- |
| Return on Assets (ROA) | -73.5% | -117.3% | -46.1% | -53.9% | -33.4% | -18.1% | -278.9% |
| Current Ratio | 5.17x | 2.90x | 4.18x | 6.72x | 10.36x | 16.43x | 1.08x |
| Quick Ratio | 4.85x | 2.54x | 3.94x | 6.35x | 10.03x | 16.10x | 0.91x |
| Debt to Equity | 0.02x | 0.10x | 0.06x | 0.09x | 0.06x | 0.04x | -- |
| **Revenue Growth (YoY)** | -100.0% | -51.3% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -- | -7100.0% | -3900.4% | -1994.2% | -1143.4% |
| **Net Profit Margin** | -- | -- | -- | -- | -6869.3% | -3721.2% | -1906.2% | -1079.9% |
| Return on Equity (ROE) | -101.3% | -61.3% | -107.3% | -91.7% | -889.0% | -366.8% | -361.9% | -184.0% |
| Return on Assets (ROA) | -73.0% | -49.9% | -66.2% | -73.5% | -312.7% | -221.5% | -175.2% | -117.3% |
| Current Ratio | 4.83x | 9.23x | 4.67x | 5.17x | 1.54x | 2.60x | 1.95x | 2.90x |
| Quick Ratio | 4.69x | 8.78x | 4.59x | 4.85x | 1.14x | 2.03x | 1.63x | 2.54x |
| Debt to Equity | 0.12x | 0.09x | 0.20x | 0.02x | 0.19x | 0.12x | 0.13x | 0.10x |
| **Revenue Growth (YoY)** | -- | -- | -- | -100.0% | -100.0% | -100.0% | -100.0% | -75.9% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
